Overview
- A multistate enforcement action by 18 attorneys general led to a $4.87 million settlement announced Monday to resolve claims that GS Labs overcharged and misled customers during the pandemic.
- Investigators say the company charged inflated prices — up to $380 for a single COVID test and up to $1,000 for multi‑illness panels — and found nearly 30,000 customers paid above market rates.
- Court records say GS Labs told insured patients they would have no out‑of‑pocket costs but then applied administrative fees up to $49, a practice that affected about 70,000 customers and is tied to roughly $1.7 million in restitution.
- The lawsuit also alleged promised three‑day turnaround times were often missed and that many customers waited a week or longer for results, disrupting travel, work and family plans.
- GS Labs has permanently shut down, denies admitting wrongdoing, and the settlement sets out how eligible consumers in the listed 18 states can submit claims to seek shares of the restitution pools.